These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 31144225

  • 21. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W, Campagnoli T, Fughhi I, Wassouf M, Ali A, Doukky R.
    J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of absent left ventricular ejection fraction reserve with regadenoson SPECT MPI.
    Smith P, Farag A, Bhambhvani P, Iskandrian A, Hage FG.
    J Nucl Cardiol; 2022 Jun; 29(3):978-986. PubMed ID: 33089878
    [Abstract] [Full Text] [Related]

  • 23. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging.
    Farzaneh-Far A, Shaw LK, Dunning A, Oldan JD, O'Connor CM, Borges-Neto S.
    J Nucl Cardiol; 2015 Aug; 22(4):600-7. PubMed ID: 25987234
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers.
    Gowdar S, Ahlberg AW, Rai M, Perucki WH, Felpel KD, Savino JA, Alter EL, Henzlova MJ, Duvall WL.
    J Nucl Cardiol; 2020 Dec; 27(6):2320-2331. PubMed ID: 30815834
    [Abstract] [Full Text] [Related]

  • 26. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging.
    Doukky R, Hayes K, Frogge N, Balakrishnan G, Dontaraju VS, Rangel MO, Golzar Y, Garcia-Sayan E, Hendel RC.
    Circulation; 2013 Oct 08; 128(15):1634-43. PubMed ID: 24021779
    [Abstract] [Full Text] [Related]

  • 27. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL, Buiting M, Mouden M, Oostdijk AH, Timmer J, Knollema S.
    Rev Esp Med Nucl Imagen Mol; 2014 Oct 08; 33(6):346-51. PubMed ID: 24862658
    [Abstract] [Full Text] [Related]

  • 28. Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk.
    Fovino LN, Saladini G, Mormino GP, Saladini F, Razzolini R, Evangelista L.
    Ann Nucl Med; 2012 Aug 08; 26(7):559-70. PubMed ID: 22660970
    [Abstract] [Full Text] [Related]

  • 29. The reproducibility and prognostic value of serial measurements of heart rate response to regadenoson during myocardial perfusion imaging.
    Andrikopoulou E, AlJaroudi WA, Farag A, Lester D, Patel H, Iskandrian AE, Hage FG.
    Eur J Nucl Med Mol Imaging; 2016 Jul 08; 43(8):1493-502. PubMed ID: 27079736
    [Abstract] [Full Text] [Related]

  • 30. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.
    Cerqueira MD, Nguyen P, Staehr P, Underwood SR, Iskandrian AE, ADVANCE-MPI Trial Investigators.
    JACC Cardiovasc Imaging; 2008 May 08; 1(3):307-16. PubMed ID: 19356442
    [Abstract] [Full Text] [Related]

  • 31. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging.
    Gomez J, Golzar Y, Fughhi I, Olusanya A, Doukky R.
    J Nucl Cardiol; 2018 Aug 08; 25(4):1313-1323. PubMed ID: 28181156
    [Abstract] [Full Text] [Related]

  • 32. [Myocardial perfusion scintigraphy with Tc-99m MIBI in patients with left bundle branch block: Visual quantification of the anteroseptal perfusion imaging for the diagnosis of left anterior descending artery stenosis].
    Möller J, Warwick J, Bouma H.
    Cardiovasc J S Afr; 2005 Aug 08; 16(2):95-101. PubMed ID: 15915276
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials.
    Mahmarian JJ, Peterson LE, Xu J, Cerqueira MD, Iskandrian AE, Bateman TM, Thomas GS, Nabi F.
    J Nucl Cardiol; 2015 Apr 08; 22(2):248-61. PubMed ID: 25287737
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging.
    Fughhi I, Campagnoli T, Ali A, Doukky R.
    J Nucl Cardiol; 2017 Oct 08; 24(5):1571-1578. PubMed ID: 27233251
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.
    Bourque JM, Patel CA, Ali MM, Perez M, Watson DD, Beller GA.
    Circ Cardiovasc Imaging; 2013 May 01; 6(3):466-77. PubMed ID: 23547172
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.